Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells

Pancreatic islet β-cell insufficiency underlies pathogenesis of diabetes mellitus; thus, functional β-cell replacement from renewable sources is the focus of intensive worldwide effort. However, in vitro production of progeny that secrete insulin in response to physiological cues from primary human...

Full description

Bibliographic Details
Main Authors: Jonghyeob Lee, Takuya Sugiyama, Yinghua Liu, Jing Wang, Xueying Gu, Ji Lei, James F Markmann, Satsuki Miyazaki, Jun-ichi Miyazaki, Gregory L Szot, Rita Bottino, Seung K Kim
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2013-11-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/00940
id doaj-d31f04dfd2b2453cadeb139439e5ffdf
record_format Article
spelling doaj-d31f04dfd2b2453cadeb139439e5ffdf2021-05-04T22:50:10ZengeLife Sciences Publications LtdeLife2050-084X2013-11-01210.7554/eLife.00940Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cellsJonghyeob Lee0Takuya Sugiyama1Yinghua Liu2Jing Wang3Xueying Gu4Ji Lei5James F Markmann6Satsuki Miyazaki7Jun-ichi Miyazaki8Gregory L Szot9Rita Bottino10Seung K Kim11Department of Developmental Biology, Stanford University School of Medicine, Stanford, United StatesDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, United StatesDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, United StatesDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, United StatesDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, United StatesDepartment of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, United StatesDepartment of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, United StatesDivision of Stem Cell Regulation Research, Osaka University Graduate School of Medicine, Osaka, JapanDivision of Stem Cell Regulation Research, Osaka University Graduate School of Medicine, Osaka, JapanUCSF Transplantation Surgery, University of California, San Francisco, San Francisco, United StatesDepartment of Pediatrics, Division of Immunogenetics, Children’s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, United StatesDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, United States; Department of Medicine, Oncology Division, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, United StatesPancreatic islet β-cell insufficiency underlies pathogenesis of diabetes mellitus; thus, functional β-cell replacement from renewable sources is the focus of intensive worldwide effort. However, in vitro production of progeny that secrete insulin in response to physiological cues from primary human cells has proven elusive. Here we describe fractionation, expansion and conversion of primary adult human pancreatic ductal cells into progeny resembling native β-cells. FACS-sorted adult human ductal cells clonally expanded as spheres in culture, while retaining ductal characteristics. Expression of the cardinal islet developmental regulators Neurog3, MafA, Pdx1 and Pax6 converted exocrine duct cells into endocrine progeny with hallmark β-cell properties, including the ability to synthesize, process and store insulin, and secrete it in response to glucose or other depolarizing stimuli. These studies provide evidence that genetic reprogramming of expandable human pancreatic cells with defined factors may serve as a general strategy for islet replacement in diabetes.https://elifesciences.org/articles/00940diabetesisletpancreasbeta-cellinsulinconversion
collection DOAJ
language English
format Article
sources DOAJ
author Jonghyeob Lee
Takuya Sugiyama
Yinghua Liu
Jing Wang
Xueying Gu
Ji Lei
James F Markmann
Satsuki Miyazaki
Jun-ichi Miyazaki
Gregory L Szot
Rita Bottino
Seung K Kim
spellingShingle Jonghyeob Lee
Takuya Sugiyama
Yinghua Liu
Jing Wang
Xueying Gu
Ji Lei
James F Markmann
Satsuki Miyazaki
Jun-ichi Miyazaki
Gregory L Szot
Rita Bottino
Seung K Kim
Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells
eLife
diabetes
islet
pancreas
beta-cell
insulin
conversion
author_facet Jonghyeob Lee
Takuya Sugiyama
Yinghua Liu
Jing Wang
Xueying Gu
Ji Lei
James F Markmann
Satsuki Miyazaki
Jun-ichi Miyazaki
Gregory L Szot
Rita Bottino
Seung K Kim
author_sort Jonghyeob Lee
title Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells
title_short Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells
title_full Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells
title_fullStr Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells
title_full_unstemmed Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells
title_sort expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells
publisher eLife Sciences Publications Ltd
series eLife
issn 2050-084X
publishDate 2013-11-01
description Pancreatic islet β-cell insufficiency underlies pathogenesis of diabetes mellitus; thus, functional β-cell replacement from renewable sources is the focus of intensive worldwide effort. However, in vitro production of progeny that secrete insulin in response to physiological cues from primary human cells has proven elusive. Here we describe fractionation, expansion and conversion of primary adult human pancreatic ductal cells into progeny resembling native β-cells. FACS-sorted adult human ductal cells clonally expanded as spheres in culture, while retaining ductal characteristics. Expression of the cardinal islet developmental regulators Neurog3, MafA, Pdx1 and Pax6 converted exocrine duct cells into endocrine progeny with hallmark β-cell properties, including the ability to synthesize, process and store insulin, and secrete it in response to glucose or other depolarizing stimuli. These studies provide evidence that genetic reprogramming of expandable human pancreatic cells with defined factors may serve as a general strategy for islet replacement in diabetes.
topic diabetes
islet
pancreas
beta-cell
insulin
conversion
url https://elifesciences.org/articles/00940
work_keys_str_mv AT jonghyeoblee expansionandconversionofhumanpancreaticductalcellsintoinsulinsecretingendocrinecells
AT takuyasugiyama expansionandconversionofhumanpancreaticductalcellsintoinsulinsecretingendocrinecells
AT yinghualiu expansionandconversionofhumanpancreaticductalcellsintoinsulinsecretingendocrinecells
AT jingwang expansionandconversionofhumanpancreaticductalcellsintoinsulinsecretingendocrinecells
AT xueyinggu expansionandconversionofhumanpancreaticductalcellsintoinsulinsecretingendocrinecells
AT jilei expansionandconversionofhumanpancreaticductalcellsintoinsulinsecretingendocrinecells
AT jamesfmarkmann expansionandconversionofhumanpancreaticductalcellsintoinsulinsecretingendocrinecells
AT satsukimiyazaki expansionandconversionofhumanpancreaticductalcellsintoinsulinsecretingendocrinecells
AT junichimiyazaki expansionandconversionofhumanpancreaticductalcellsintoinsulinsecretingendocrinecells
AT gregorylszot expansionandconversionofhumanpancreaticductalcellsintoinsulinsecretingendocrinecells
AT ritabottino expansionandconversionofhumanpancreaticductalcellsintoinsulinsecretingendocrinecells
AT seungkkim expansionandconversionofhumanpancreaticductalcellsintoinsulinsecretingendocrinecells
_version_ 1721477262538178560